Final results of the Minnie Pearl Cancer Research Network first-line trial of weekly paclitaxel/carboplatin/trastuzumab in metastatic breast cancer.

被引：0
|
作者：
Yardley, DA
Greco, FA
Hainsworth, JD
Houston, GA
Broome, CM
Bramham, J
Patton, JF
Thompson, DS
Erland, JS
White, MB
Burris, HA
机构：
[1] Sarah Cannon Canc Ctr Tennessee Oncol, PLLC, Nashville, TN USA
[2] Jackson Oncol Associates, Jackson, MS USA
[3] No Virginia Oncol Grp PC, Fairfax, VA USA
[4] Graves Gilbert Clin, Bowling Green, KY USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [31] Bevacizumab Combined with Two-weekly Paclitaxel as First-line Therapy for Metastatic Breast Cancer
    Kountourakis, Panteleimon
    Doufexis, Dimitrios
    Maliou, Savoula
    Karagiannis, Athanasios
    Kardara, Eugenia
    Margari, Charalampia
    Sykoutri, Despoina
    Tzovaras, Alexandros
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2010, 30 (07) : 2969 - 2971
  • [32] Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer
    Valerio, M. R.
    Fulfaro, F.
    Cicero, G.
    Rinaldi, G.
    Maiorana, O.
    Spinnato, F.
    Intrivici, C.
    Crosta, A.
    Scibilia, C.
    Pizzo, T.
    Vanella, P.
    Gebbia, N.
    ANNALS OF ONCOLOGY, 2006, 17 : VII147 - VII147
  • [33] Weekly paclitaxel (PCT) ± trastuzumab (T) as first-line therapy of patients (pts) with HER-2/NEU positive metastatic breast cancer (MBC):: final results of a multicenter randomized phase IIb trial
    Gasparini, G
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S94 - S94
  • [34] Phase III trial evaluating paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer
    Tong, Zhongsheng
    Li, Shufen
    Shi, Yehui
    Wang, Xu
    Hao, Chunfang
    He, Lihong
    Dong, Guolei
    Wang, Xiaorui
    Jia, Yongsheng
    Zhang, Li
    CANCER RESEARCH, 2015, 75
  • [35] A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer
    David M. Loesch
    Lina Asmar
    Vikki A. Canfield
    Gregory A. Parker
    Harry E. Hynes
    Peter G. Ellis
    William A. Ferri
    Nicholas J. Robert
    Breast Cancer Research and Treatment, 2003, 77 : 115 - 123
  • [36] A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer
    Loesch, DM
    Asmar, L
    Canfield, VA
    Parker, GA
    Hynes, HE
    Ellis, PG
    Ferri, WA
    Robert, NJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (02) : 115 - 123
  • [37] Phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer
    Danso, M. A.
    Blum, J. L.
    Robert, N. J.
    Krekow, L.
    Rotche, R.
    Smith, D. A.
    Richards, P.
    Anderson, T.
    Richards, D. A.
    O'Shaughnessy, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] WEEKLY PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY PLUS TRASTUZUMAB IN PTS WITH ADVANCED BREAST CANCER, C-ERBB2 3+
    Lanza, R.
    Proietto, M.
    Calabro, P.
    Marchei, P.
    ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [39] Carboplatin (C) followed by sequential weekly paclitaxel (T) and gemcitabine (G) as first-line treatment for ovarian cancer.
    Perren, T
    Gore, M
    Hall, G
    Everard, M
    A'Hern, R
    Cole, C
    Gibbens, I
    Jenkins, A
    Kaye, S
    BRITISH JOURNAL OF CANCER, 2003, 88 : S58 - S58
  • [40] Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    McClurkan, S
    Gray, JR
    Stroup, SL
    Burris, HA
    Yardley, DA
    Bradof, JE
    Yost, K
    Ellis, JK
    Greco, FA
    CANCER JOURNAL, 2002, 8 (04): : 311 - 321
12345